To explore the prognostic value of the AC005154.6/hsa-miR-29c-3p/CCNL2 network, we assessed the role of this axis in the PFS of PRAD patients (Additional file 6: Table S4). Here, CCNL2 is linked to prostate adenocarcinoma.